HELM AG, Welding and 5MED establish new joint venture ANESTPHARMA
London, UK and Hamburg, Germany (June 7th, 2022)
ANESTPHARMA will be dedicated to Anesthesiology and Intensive Care Medicine. The mission is to increase efficiency in anesthesiology departments and Intensive Care Units all over Europe by increasing the quality of care and reducing resource requirements through innovative products and services. The vision of ANESTPHARMA is to deliver and commercialize innovations with a quantifiable value-add for the patient, the healthcare professional as well as the payer in this specialty care market through agile approaches.
The joint venture is a significant step for all three parties by providing a direct marketing structure with its own sales force. The partnership is effective as of now and cooperation has already started.
One of the first products to be distributed by ANESTPHARMA, will be an analgesic on fentanyl base, which can be applied self-administered over a nasal self-application system. The initial launch will be focused on key European countries.
“With ANESTPHARMA we have the opportunity to contribute to improving the quality in European hospitals for the benefit of patients and to bring innovative products exactly where they are needed”, as Bernd Stoiber, Member of the Executive Board at HELM, explains.
Dr. Stefan Nardi-Hiebl, Managing Director at 5MED highlights: “We are very excited to be a part of this joint venture where we see incredible opportunities to build a fast-moving organization that can challenge traditional companies, by providing new and necessary niche hospital products with a measurable value-add.”
As a first public appearance, ANESTPHARMA will be attending the BIO International Convention (13th - 15th of June 2022) in San Diego, to present itself to the industry and to discuss opportunities for commercial collaborations. "We are excited to participate for the first time as ANESTPHARMA in such an international context and look forward to make new contacts in the fields of Anesthesiology, Intensive Care medicine and beyond", states Lars Hallmayer, Managing Director at Welding.
HELM is a Hamburg, Germany, based family-owned company established in 1900. HELM is one of the world’s largest chemicals marketing companies and committed to providing solutions to its partners worldwide. The company secures access to the world’s key markets through its specific regional knowledge and its multinational presence. As a multifunctional marketing organization HELM is active in the chemicals industry, in the crop protection industry, in pharmaceuticals and in the fertilizer industry.
Welding is based in the German city of Hamburg and has built an excellent reputation in the pharmaceutical industry for leading projects from start to finish. Since 1955, Welding has been involved in the supply of APIs, accruing experience in identifying and handling the ingredients and connecting their suppliers to the manufacturers of finished dosage forms.
5MED is a specialized company focusing on the sourcing and development of technical solutions for anesthesiology and intensive care medicine. Founded by anesthesiologists, pain nurses and professionals from the industry in 2012, 5MED evaluates ideas from the daily practice and transforms the ones with value-add into products to improve the quality of care while reducing the cost burden for healthcare systems.